Evaluation of the Adherence and the Patient Acceptability of Zomacton Treatment With the Zomajet Vision X Device
Phase of Trial: Phase IV
Latest Information Update: 15 May 2015
Price : $35 *
At a glance
- Drugs Somatrogon (Primary)
- Indications Somatotropin deficiency; Turner's syndrome
- Focus Therapeutic Use
- Acronyms ZOMAXEPT
- Sponsors Ferring Pharmaceuticals
- 11 May 2015 Status changed from recruiting to discontinued, as reported by ClinicalTrial.gov.
- 18 Nov 2014 Planned End Date changed from 1 Feb 2018 to 1 Mar 2018 as reported by ClinicalTrial.gov record.
- 16 Jul 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrial.gov record.